Table 2.
KEGG pathway enrichment of these DEGs.
| Category | Term | RT | Count | % | P value | Benjamini |
|---|---|---|---|---|---|---|
| KEGG_PATHWAY | Renal cell carcinoma | RT | 8 | 1.9 | 5.10E-04 | 6.00E-02 |
| KEGG_PATHWAY | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | RT | 8 | 1.9 | 8.40E-04 | 5.00E-02 |
| KEGG_PATHWAY | Neurotrophin signaling pathway | RT | 9 | 2.1 | 3.60E-03 | 1.40E-01 |
| KEGG_PATHWAY | Cell cycle | RT | 9 | 2.1 | 3.80E-03 | 1.10E-01 |
| KEGG_PATHWAY | Pancreatic cancer | RT | 6 | 1.4 | 1.50E-02 | 3.10E-01 |
| KEGG_PATHWAY | Chronic myeloid leukemia | RT | 6 | 1.4 | 1.80E-02 | 3.10E-01 |
| KEGG_PATHWAY | Progesterone-mediated oocyte maturation | RT | 6 | 1.4 | 3.10E-02 | 4.20E-01 |
| KEGG_PATHWAY | Regulation of actin cytoskeleton | RT | 10 | 2.4 | 3.10E-02 | 3.80E-01 |
| KEGG_PATHWAY | Base excision repair | RT | 4 | 1 | 3.40E-02 | 3.70E-01 |
| KEGG_PATHWAY | Pathways in cancer | RT | 13 | 3.1 | 3.40E-02 | 3.50E-01 |